Oncologic Emergencies

Catherine L. Oberg, Glen B. Chun

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Oncologic emergencies encompass a variety of clinical entities including tumor lysis syndrome (TLS), superior vena cava syndrome, neutropenic fever, and symptomatic leukostasis (SL). This chapter provides a detailed discussion on the prevention, diagnosis, treatment, and prognosis of oncologic emergencies. TLS is most commonly associated with hematologic malignancies. The best treatment for TLS is prevention, employing continuous cardiac monitoring, serial laboratory evaluations (electrolytes, renal function, uric acid) every 4–6 hours, and rasburicase 0.2 mg/kg with repeated dosing as needed in high risk patients. SL occurs in the setting of hyperleukocytosis, commonly seen in patients with acute myeloid leukemia or chronic myeloid leukemia in blast crisis, in which leukocyte plugs in the microvasculature decrease tissue perfusion.

Original languageEnglish
Title of host publicationMount Sinai Expert Guides
Subtitle of host publicationCritical Care
Publisherwiley
Pages586-595
Number of pages10
ISBN (Electronic)9781119293255
ISBN (Print)9781119293262
DOIs
StatePublished - 1 Jan 2020

Keywords

  • Hematologic malignancies
  • Neutropenic fever
  • Oncologic emergencies
  • Superior vena cava syndrome
  • Symptomatic leukostasis
  • Tumor lysis syndrome

Fingerprint

Dive into the research topics of 'Oncologic Emergencies'. Together they form a unique fingerprint.

Cite this